Unknown

Dataset Information

0

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.


ABSTRACT: Extracellular vesicles (EVs) are lipid membrane-enclosed nanoparticles released by cells. They mediate intercellular communication by transferring biological molecules and therefore have potential as innovative drug delivery vehicles. TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis of cancer cells. Unfortunately, the clinical application of recombinant rTRAIL has been hampered by its low bioavailability and resistance of cancer cells. EV-mediated TRAIL delivery may circumvent these problems. Mesenchymal stromal cells (MSCs) produce EVs and could be a good source for therapeutic EV production. We investigated if TRAIL could be expressed in MSC-derived EVs and examined their cancer cell-killing efficacy. EVs were isolated by ultracentrifugation and were membranous particles of 50-70 nm in diameter. Both MSC- and TRAIL-expressing MSC (MSCT)-derived EVs express CD63, CD9 and CD81, but only MSCT-EVs express surface TRAIL. MSCT-EVs induced apoptosis in 11 cancer cell lines in a dose-dependent manner but showed no cytotoxicity in primary human bronchial epithelial cells. Caspase activity inhibition or TRAIL neutralisation blocked the cytotoxicity of TRAIL-positive EVs. MSCT-EVs induced pronounced apoptosis in TRAIL-resistant cancer cells and this effect could be further enhanced using a CDK9 inhibitor. These data indicate that TRAIL delivery by MSC-derived EVs is an effective anticancer therapy.

SUBMITTER: Yuan Z 

PROVIDER: S-EPMC5328331 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy.

Yuan ZhengQiang Z   Kolluri Krishna K KK   Gowers Kate H C KH   Janes Sam M SM  

Journal of extracellular vesicles 20170118 1


Extracellular vesicles (EVs) are lipid membrane-enclosed nanoparticles released by cells. They mediate intercellular communication by transferring biological molecules and therefore have potential as innovative drug delivery vehicles. TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis of cancer cells. Unfortunately, the clinical application of recombinant rTRAIL has been hampered by its low bioavailability and resistance of cancer cells. EV-mediated TRAIL delivery may ci  ...[more]

Similar Datasets

| S-EPMC7335740 | biostudies-literature
| S-EPMC7806483 | biostudies-literature
| S-EPMC6468445 | biostudies-literature
| S-EPMC9055911 | biostudies-literature
| S-EPMC8036951 | biostudies-literature
| S-EPMC7062641 | biostudies-literature
| S-EPMC8609070 | biostudies-literature
| S-EPMC8741238 | biostudies-literature
| S-EPMC5425726 | biostudies-literature
2018-05-21 | GSE99082 | GEO